ICU immune cell study halted: what it could have revealed
NCT ID NCT06415474
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study aimed to track how different immune cells (lymphocytes) change over time in ICU patients with severe infections or injuries. Researchers hoped to better understand 'immunoparalysis,' a state where the immune system becomes weak after severe inflammation. The study was terminated after enrolling 38 participants, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING ESOPHAGECTOMY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Brest
Brest, 29609, France